| Product Code: ETC8541807 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Liraglutide Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Liraglutide Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Liraglutide Market - Industry Life Cycle |
3.4 Netherlands Liraglutide Market - Porter's Five Forces |
3.5 Netherlands Liraglutide Market Revenues & Volume Share, By Brands, 2021 & 2031F |
4 Netherlands Liraglutide Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in the Netherlands |
4.2.2 Growing awareness about the benefits of liraglutide in managing diabetes |
4.2.3 Favorable government initiatives promoting the use of liraglutide in diabetes treatment |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval and pricing |
4.3.2 Competition from alternative diabetes management therapies |
4.3.3 Potential side effects associated with liraglutide impacting adoption rates |
5 Netherlands Liraglutide Market Trends |
6 Netherlands Liraglutide Market, By Types |
6.1 Netherlands Liraglutide Market, By Brands |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Liraglutide Market Revenues & Volume, By Brands, 2021- 2031F |
6.1.3 Netherlands Liraglutide Market Revenues & Volume, By Victoza, 2021- 2031F |
6.1.4 Netherlands Liraglutide Market Revenues & Volume, By Saxenda, 2021- 2031F |
7 Netherlands Liraglutide Market Import-Export Trade Statistics |
7.1 Netherlands Liraglutide Market Export to Major Countries |
7.2 Netherlands Liraglutide Market Imports from Major Countries |
8 Netherlands Liraglutide Market Key Performance Indicators |
8.1 Patient adherence rate to liraglutide treatment |
8.2 Number of healthcare professionals prescribing liraglutide |
8.3 Rate of new clinical studies supporting the efficacy of liraglutide in diabetes management |
9 Netherlands Liraglutide Market - Opportunity Assessment |
9.1 Netherlands Liraglutide Market Opportunity Assessment, By Brands, 2021 & 2031F |
10 Netherlands Liraglutide Market - Competitive Landscape |
10.1 Netherlands Liraglutide Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Liraglutide Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |